Retinopathy is damage to the blood vessels in the retina, the light-sensitive tissue lining the back of your eye. It most commonly results from diabetes or high blood pressure, though direct sun exposure and other conditions can also cause it. The hallmark of retinopathy is that tiny blood vessels in the retina weaken, leak fluid, or grow abnormally, gradually threatening your vision. In its early stages, retinopathy typically causes no symptoms at all, which is why routine eye screening matters so much.
How Retinal Blood Vessels Break Down
Your retina is packed with small blood vessels that deliver oxygen and nutrients to the cells responsible for vision. In retinopathy, those vessels become damaged at a structural level. The walls of the vessels weaken, allowing blood, fluid, and fatty deposits to leak into the surrounding retinal tissue. This leakage causes swelling (called edema), which distorts the signals your retina sends to your brain.
When enough vessels become blocked or damaged, parts of the retina stop receiving adequate blood flow. The retina responds by triggering the growth of new blood vessels to compensate. That sounds helpful, but these replacement vessels are fragile and poorly formed. They rupture easily, spilling blood into the interior of the eye. This is the point where retinopathy becomes most dangerous to your sight.
Diabetic Retinopathy
Diabetes is the most common cause of retinopathy worldwide. Persistently high blood sugar generates harmful molecules called reactive oxygen species inside the cells lining retinal blood vessels. These molecules set off a chain of inflammatory damage: the vessel walls become more permeable, immune cells infiltrate the retina, and tissue swelling follows. Over time, the damage compounds.
Diabetic retinopathy progresses through two broad phases. The first, nonproliferative diabetic retinopathy (NPDR), ranges from mild to severe. In its mildest form, tiny balloon-like bulges called microaneurysms appear on vessel walls. As it worsens, small bleeds and fatty deposits accumulate across the retina, and patches of tissue begin losing their blood supply. Severe NPDR means widespread bleeding and visible signs of vessel distress in multiple areas of the retina.
The second phase, proliferative diabetic retinopathy (PDR), is defined by the growth of those fragile new blood vessels. If these vessels bleed into the gel-like substance filling the eye (the vitreous), you may notice a few dark floating spots in mild cases. In severe cases, blood can fill the entire vitreous cavity and block your vision completely. PDR can also cause scar tissue to form, which may pull on the retina and detach it.
Blood Sugar Thresholds and Risk
The connection between blood sugar control and retinopathy risk is dose-dependent. Research on HbA1c levels (a measure of average blood sugar over two to three months) found that people with levels between 6.5% and 6.9% were roughly 2.4 times more likely to develop retinopathy within three years compared to those with levels between 5.0% and 5.4%. Below 6.5%, there was no significant increase in risk. The takeaway: keeping HbA1c below 6.5% substantially lowers your chances of retinal damage.
Hypertensive Retinopathy
Chronic high blood pressure damages retinal vessels through a different mechanism. Elevated pressure is transmitted directly into the small arteries of the retina, initially causing them to narrow as a protective response. When blood pressure stays high or spikes severely, that compensatory narrowing fails. The smooth muscle and inner lining of the vessels sustain direct injury.
As the damage progresses, the barrier between the blood and the retina breaks down. Blood, fluid, and fats leak through compromised vessel walls. Areas of the retina lose their oxygen supply, producing pale patches called cotton wool spots, which represent tiny zones of nerve fiber death. In the most severe form, associated with dangerously high blood pressure (malignant hypertension), the optic disc itself swells, and widespread hemorrhages and fluid deposits appear across the retina. Controlling blood pressure is the primary way to prevent and slow this type of retinopathy.
Other Types of Retinopathy
Solar retinopathy occurs when intense light, particularly from staring at the sun or an eclipse, damages the central part of the retina (the fovea). The injury is photochemical: blue light wavelengths trigger a chain reaction that destroys pigment cells and the light-sensing cells above them through a process similar to oxidation. The damage can be permanent, leaving a small blind spot in central vision. Unlike diabetic or hypertensive retinopathy, solar retinopathy results from a single exposure event rather than a chronic condition.
Retinopathy of prematurity affects infants born very early, whose retinal blood vessels haven’t finished developing. Sickle cell disease, radiation exposure, and certain medications can also cause retinal vascular damage, though these are less common.
Symptoms and What to Watch For
Early retinopathy is almost always silent. You can have significant vessel damage without noticing any change in your vision, which is why the condition is often caught during a routine dilated eye exam rather than from symptoms alone.
As the disease advances, symptoms typically include:
- Floaters: dark spots or strings drifting across your field of vision, caused by small amounts of blood leaking into the vitreous
- Blurred vision: often from fluid accumulating in the macula, the part of the retina responsible for sharp central sight
- Dark or empty areas: patches of vision loss corresponding to retinal regions that have lost blood supply
- Sudden vision loss: a sign of a large vitreous hemorrhage or retinal detachment, both of which require urgent care
Any sudden change in vision, whether blurriness, new floaters, or dark patches, warrants prompt medical attention.
How Retinopathy Is Diagnosed
A dilated eye exam is the standard screening tool. Drops widen your pupils so an eye care provider can examine the retina directly, looking for microaneurysms, hemorrhages, fatty deposits, cotton wool spots, and abnormal new vessel growth.
Optical coherence tomography (OCT) provides a cross-sectional scan of the retina, measuring its thickness in microns. The central 1-millimeter zone of the retina is the key measurement used to track macular edema. On an OCT scan, fluid collections appear as dark pockets within or beneath the retinal layers, making it straightforward to identify swelling and monitor whether it’s getting better or worse over time. Fluorescein angiography, where a dye is injected into your arm and photographed as it travels through retinal vessels, can reveal areas of leakage and blocked blood flow.
Screening Recommendations
If you have type 1 diabetes, the American Academy of Ophthalmology recommends annual dilated eye exams starting five years after diagnosis. If you have type 2 diabetes, screening should happen at the time of diagnosis and at least once every year after that. The difference reflects the fact that type 2 diabetes often goes undetected for years before diagnosis, meaning retinal damage may already be present.
For people with high blood pressure, retinal screening is typically part of managing the condition, especially when blood pressure is difficult to control or has reached severe levels.
Treatment Options
Injections That Block Abnormal Vessel Growth
The most widely used treatments for retinopathy-related vision loss are injections delivered directly into the eye. These drugs work by blocking a protein called VEGF, which signals the retina to grow new (and problematic) blood vessels. By neutralizing that signal, the injections reduce leakage from existing vessels, slow or stop the growth of fragile new ones, and decrease macular swelling. Patients typically notice stabilized or improved vision, though multiple injections over months are usually needed.
Several of these drugs exist, with varying potency and duration. Some bind only one form of the VEGF protein, while newer versions target multiple forms along with other growth factors. Your eye specialist will choose based on the severity of your condition and how your eyes respond over time.
Laser Treatment
Pan-retinal photocoagulation (PRP) is the established laser procedure for proliferative diabetic retinopathy. It involves applying hundreds of tiny laser burns across the peripheral retina, which reduces the retina’s oxygen demand and slows the drive to grow abnormal vessels. PRP has been shown to reduce the risk of severe vision loss by 50%. It is generally better at preserving existing vision than restoring vision already lost, though it can help in some cases, such as when bleeding in the vitreous clears.
Laser treatment is not typically used for nonproliferative retinopathy. At that stage, the risks of the procedure, including some loss of peripheral and night vision from the laser burns themselves, outweigh the benefits.
What Recovery Looks Like
After an eye injection, your eye may feel gritty or sore for a day or two. Vision can be blurry immediately afterward but typically clears within hours. You’ll need follow-up visits, often monthly at first, to check whether swelling has decreased and whether additional injections are needed. After laser treatment, vision may be blurry for a few days, and some people notice a mild decrease in peripheral vision or night vision permanently. Both treatments aim to hold the line against further damage rather than reverse it entirely, which is why catching retinopathy early gives you the best chance of keeping your sight intact.